A Look Into AstraZeneca's Debt
Portfolio Pulse from Benzinga Insights
AstraZeneca Inc. (NASDAQ:AZN) has seen its shares decrease by 10.16% over the past three months. The company's total debt stands at $16.81 billion, with $14.50 billion in long-term debt and $2.31 billion in current debt. After adjusting for $5.02 billion in cash-equivalents, the net debt is $11.79 billion. The company's debt-ratio is 0.27, indicating a moderate level of financial leverage.
July 07, 2023 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AstraZeneca's shares have decreased by 10.16% over the past three months. The company's total debt is $16.81 billion, with a net debt of $11.79 billion. The debt-ratio of 0.27 indicates a moderate level of financial leverage.
The decrease in AstraZeneca's share price over the past three months could be partially attributed to its high level of debt. The company's debt-ratio of 0.27, while not excessively high, still indicates a moderate level of financial leverage, which could be a concern for investors. This could potentially lead to further decreases in the company's share price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100